IRIS - Res&Arch Institutional Research Information System - Research & Archive

PUXEDDU, Efisio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.056
EU - Europa 2.977
AS - Asia 647
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 2
AF - Africa 1
Totale 6.692
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.051
UA - Ucraina 707
SE - Svezia 540
IE - Irlanda 512
IT - Italia 327
FR - Francia 325
HK - Hong Kong 274
VN - Vietnam 243
FI - Finlandia 140
DE - Germania 133
RU - Federazione Russa 118
CN - Cina 84
GB - Regno Unito 60
BE - Belgio 30
CH - Svizzera 24
KR - Corea 21
RO - Romania 12
NL - Olanda 9
AT - Austria 8
EU - Europa 8
GR - Grecia 8
PL - Polonia 7
TR - Turchia 7
BG - Bulgaria 6
SG - Singapore 6
CZ - Repubblica Ceca 5
LB - Libano 4
UZ - Uzbekistan 4
EE - Estonia 2
MX - Messico 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BR - Brasile 1
CA - Canada 1
CI - Costa d'Avorio 1
ES - Italia 1
GL - Groenlandia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.692
Salva come PNG Salva come JPEG
Città #
Chandler 715
Dublin 512
Jacksonville 398
San Mateo 282
Hong Kong 274
Dong Ket 243
Medford 148
Princeton 145
Altamura 124
Wilmington 121
Ann Arbor 104
Lawrence 96
Andover 93
Perugia 60
Beijing 51
Saint Petersburg 38
Woodbridge 38
Ashburn 30
Brussels 30
Des Moines 30
Redmond 27
Boardman 26
Auburn Hills 23
Falls Church 23
Norwalk 19
Shanghai 18
San Paolo di Civitate 17
New York 16
Helsinki 15
Los Angeles 15
Bucharest 12
Lausanne 9
Moscow 9
Fremont 8
Redwood City 8
Houston 7
Rome 7
Den Haag 6
Izmir 6
Chicago 5
Edinburgh 5
Frankfurt Am Main 5
San Diego 5
San Jose 5
Sasso Marconi 5
Macerata 4
Osimo 4
Phoenix 4
Singapore 4
Solon 4
Anguillara Sabazia 3
Guangzhou 3
Montalto delle Marche 3
Philadelphia 3
Tappahannock 3
Terni 3
Amelia 2
Assisi 2
Bologna 2
Dallas 2
Fiorenzuola D'arda 2
Ivrea 2
Jesi 2
Kiev 2
Lappeenranta 2
Milan 2
Mountain View 2
Nanjing 2
Nanning 2
Naples 2
Napoli 2
Palermo 2
San Giuliano 2
Seoul 2
Stockholm 2
Taiyuan 2
Tallinn 2
Verona 2
West Jordan 2
Abidjan 1
Amsterdam 1
Athens 1
Atlanta 1
Ballymena 1
Belgrade 1
Biel/Bienne 1
Buffalo 1
Castello 1
Chieti 1
Coraopolis 1
Costa Mesa 1
Cuauhtémoc 1
Dambulla 1
Denver 1
Florence 1
Formigine 1
Guadalajara 1
Hermosillo 1
Istanbul 1
Kuala Lumpur 1
Totale 3.938
Salva come PNG Salva come JPEG
Nome #
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 96
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 92
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF). 90
L’ecografia intraoperatoria nella chirurgia delle recidive del cancro differenziato della tiroide. 88
Search of ret/ptc rearrangement and braf and ras mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of braf mutation and allowed to detect a new mutation of braf oncoprotein 80
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. 80
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 80
Etiopatogenesi dei carcinomi della tiroide che originano dall’epitelio follicolare 79
The role of BRAF V6ooE in regulating the expression of proangiogenic factors in papillary thyroid carcinomas : in vivo and in vitro analysis. 75
A usefull ultrasound score to select thyroid nodules requiring FNA in an iodine area 74
Medicina molecolare in chirurgia della tiroide 74
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 73
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 72
Analisi del meccanismo dominante inibitorio esercitato in cis dalle mutazioni inattivanti D594V e G596R sulla mutazione attivante di BRAF V600E 71
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 71
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 70
Primitive thyroid lymphomas 70
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 69
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. 67
Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study 67
Caratterizzazione biochimica e molecolare della nuova mutazione BRAFV599Ins recentemente individuata in un carcinoma papillare della tiroide 67
A useful ultrasound score to select thyroid nodules requiring fine needle aspiration in an iodine-deficient area. 66
The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice. 66
Analisi della espressione degli oncogeni RET/PTC e del proto-oncogene RET in una coorte di carcinomi papillari della tiroide sporadici e correlazione con le caratteristiche clinico-patologiche delle neoplasie 66
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. 65
Revisione della casistica dei pazienti affetti da oftalmopatia basedowiana seguiti presso il Dipartimento di Medicina Interna dell’Università degli Studi di Perugia negli anni 1990-2007 64
Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome. 64
L’analisi proteomica del carcinoma papillare della tiroide evidenzia modificazioni dello stato ossidoriduttivo e della struttura delle cellule tumorali 64
B-RAF activating mutations inhibit genes related to intrathyroidal iodine metabolism in papillary thyroid carcinoma 63
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon? 63
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer 63
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer 63
. Indoleamine 2,3-dioxygenase expression in papillary thyroid carcinoma : study of its correlation with tumor genetics and clinical behaviour 62
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 62
Androgen Receptor Mutations in Prostate Cancer 62
Molecular dynamic simulations of the catalytic domain of BRAF in response to activating and inactivating mutations 60
La mutazione V599E dell’oncogene BRAF rappresenta l’alterazione genetica più frequente nei carcinomi papillari della tiroide sporadici dell’adulto 60
Clinical implications of BRAF mutation in thyroid carcinoma 60
Confronto tra citologia aspirativa con ago sottile e parametri eco-color-doppler nei noduli tiroidei 59
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors. 59
Diagnostic-therapeutic pathways as instruments of clinical management: experience at the S. Maria Hospital in Terni 58
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer 58
Surgical treatment of medullary thyroid carcinoma (MTC) 57
Le sostituzioni aminoacidiche G596R e D594V hanno un effetto inibitorio dominante sulla funzione della mutazione V600E di BRAF 56
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 56
Isozyme-specific abnormalities of protein kinase C in thyroid cancer: evidence for epigenetic changes in PKC epsilon 55
Comparison between fine needle aspiration cytology and ultrasound features in thyroid nodules: an US score to select thyroid nodules requiring FNA. 55
Liver alcoholic cirrhosis and spur-cell (acanthocytic) anaemia. A study of erythrocyte ghost composition and fluidity 55
Conditional expression of RET/PTC3 in PCCL3 cells induces microsomal Prostaglandin E Synthase expression and Prostaglandin E2 biosynthesis through the activation of MEK-ERK pathway 54
BRAF mutations and RET/PTC rearrangements in an italian thyroid tumor cohort 54
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 54
Search of RET/PTC rearrangement and BRAF and RAS mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of BRAF mutation and allowed to detect a new mutation of BRAF oncoprotein 53
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 53
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. 53
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells 52
Caratterizzazione di un riarrangiamento non clonale tra i geni H4 e PTEN (H4/PTEN) in cellule tiroidee umane e in campioni di carcinoma papillare della tiroide 52
Recurrence of thyroid well differentiated cancer: ultrasonography-guided surgical treatment 52
Severe spruelike enteropathy due to olmesartan 52
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation 52
Surgical treatment of primitive thyroid lymphoma 51
Ventilatory response to exercise in diabetic subjects with autonomic neuropathy 51
Patogenesi del carcinoma della tiroide 51
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) 51
The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition 51
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 50
Surgical treatment of differenziated thyroid carcinoma: a retrospective study 49
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. 49
Lo studio dell’espressione genica indotta da RET/PTC nella linea cellulare PCCL3 evidenzia l’attivazione precoce di geni coinvolti nella regolazione della risposta immunitaria. 48
Acromegaly is associated with increased cancer risk: a survey in Italy 48
Aspetti di biologia molecolare degli ipertiroidismi 48
Characterization of a non-clonal intrachromosomal rearrangement between the H4 and the PTEN gene (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 47
Epigenetics of thyroid cancer and novel therapeutic targets. 47
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 47
Braf mutation testing in fnac samples increases accuracy of thyroid cytology in a region of high braf mutation prevalence 46
Synthesis of phosphatidylserine by base exchange in rat cerebellum and cortex 46
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 46
Iodide transporters NIS and AIT-B mRNA expression in papillary thyroid carcinomas carrying the BRAFV600E mutation 45
Surgical Treatment of sporadic medullary carcinoma: our strategy and outcome of treatment 45
Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 45
Evaluation of goiter using ultrasound criteria: a survey in a middle schoolchildren population of a mountain area in Central Italy. 45
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 44
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 43
Caratteristiche genetiche di una coorte di carcinomi papillari della tiroide raccolta in Umbria e loro significato clinico 43
G.M.R. per le neoplasie tiroidee della regione Umbria: primo rapporto sull’attivita’ svolta 42
Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells 41
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies. 41
Proteomic analysis of papillary thyroid carcinomas reveals demodulation of signal transduction pathways, increased resistance to oxidative stress and gain of invasive phenotype. 40
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 40
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 40
Clinical prognosis in BRAF-mutated PTC 40
Oncogeni e chirurgia della tiroide 39
Sunitinib inhibits the growth of thyroid tumor xenografts in mice by acting primarily on tumor angiogenesis 39
The natural history of benign thyroid nodules 39
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 39
Persistent Hypercalcitoninemia in patients with medullary thyroid cancer 38
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 38
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 38
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 38
Genetic markers in thyroid neoplasia 37
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 37
Totale 5.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 0 17 5
2019/2020860 109 21 116 6 116 84 110 43 112 56 14 73
2020/20211.552 7 100 73 109 379 108 107 15 186 61 133 274
2021/20221.231 35 212 35 109 31 8 18 393 6 49 137 198
2022/20232.081 177 391 28 192 175 202 2 110 700 21 68 15
2023/2024615 57 104 33 18 20 6 156 28 161 25 7 0
Totale 6.993